Caroline Buckee, Department of Biostatistics Harvard TH Chan School of Public Health How do we predict the pandemic? Michael Mina, Department of Epidemiology Harvard TH Chan School of Public Health The importance and challenges of testing for COVID-19 Natalie Dean, Department of Biostatistics, University of Florida How we evaluate the efficacy of potential therapies and […]
Frontiers in Biostatistics Seminar Noah Simon, Ph.D. Associate Professor Department of Biostatistics University of Washington To build inferential or predictive survival models, it is common to assume proportionality of hazards and fit a model by maximizing the partial likelihood. This has been combined with non-parametric and high dimensional techniques, eg. spline expansions and penalties, to flexibly build […]
Frontiers in Biostatistics Webinar Marianne Menictas Postdoctoral Fellow, Department of Statistics Harvard University Mobile health (mHealth) technologies are increasingly being employed to deliver interventions to users in their natural environments. With the advent of increasingly sophisticated sensing devices (e.g., GPS) and phone-based EMA, it is becoming possible to deliver interventions at moments when they can […]
A conversation with Jeff Leek, PhD, Johns Hopkins University. Moderator: Rafael Irizarry. Registration required. https://dfci.zoom.us/webinar/register/WN_XscX-d21RqylhDCXzvP2-Q A recording of the talk is available on our YouTube channel.
Frontiers in Biostatistics Seminar Tuesday September 15, 2020 at 1:00PM Eastern Time Peter F. Thall, PhD Department of Biostatistics University of Texas M.D. Anderson Cancer Center Abstract: Conventional evaluation of a new drug, 𝐴, is done in three phases. Phase I relies on toxicity to determine a “maximum tolerable dose” (MTD) of 𝐴, in phase […]
